Previous 10 | Next 10 |
MONROE TOWNSHIP, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. ("OPT" or "the Company") (NYSE American: OPTT), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced that it will report its fiscal 2024 second q...
(NewsDirect) Philipp Stratmann, CEO of Ocean Power Technologies, shared exciting developments and initiatives aimed at achieving profitability in 2025 during an interview with Steve Darling from Proactive. One significant initiative involves the divestment of Ocean Power Technologies'...
MELBOURNE, Australia, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Company’s Founder and ...
Revenue of $11.7 million Optiva selected by three new customers Total Contract Value (“TCV”) 1 bookings of $13.6 million Gross margin of 61% Adjusted EBITDA 1 loss of $0.8 million Adjusted EPS 1 loss of ($0.76) $21.7 million of cash TORONT...
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Optiva Inc. (“Optiva” or the “Company”) (TSX: OPT), a leader in powering the telecom industry with cloud-native billing, charging and revenue management software, has been selected by REALLY , a United States-based inn...
(NewsDirect) Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to to share some exciting news. OPT has secured a substantial volume order from Sulmara, a prominent player in offshore services, for their cutting-edge WAM-V 16 uncrewed surface vehicles. ...
MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Company’s Founder &...
2023-10-27 06:11:54 ET More on Opthea Opthea raises additional capital, up to $57.6M Seeking Alpha’s Quant Rating on Opthea Historical earnings data for Opthea Financial information for Opthea For further details see: Opthea appoints U.S.-b...
Dr. Megan Baldwin transitions to Founder, Chief Innovation Officer and remains on the Board of Directors Experienced pharmaceutical executives Dr. Frederic Guerard appointed as CEO and Peter Lang appointed as CFO, bringing complementary expertise to lead Opthea’s next phase of ...
MONROE TOWNSHIP, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. ("OPT" or "the Company") (NYSE American: OPTT) , a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it has r...
News, Short Squeeze, Breakout and More Instantly...
MELBOURNE, Australia and PRINCETON, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, incl...
New Shares under the Retail Entitlement Offer and New Options under the Placement and Entitlement Offer expected to commence normal trading on Thursday, 18 July 2024 Retail Entitlement Offer follows successful Institutional Entitlement Offer and institutional Placement raising approxima...
Research underpins sozinibercept’s potential as novel, first-in-class VEGF-C/D ‘trap’ to prevent blood vessel growth and vascular leakage in the retina Published in peer-reviewed journal Ophthalmology and Therapy MELBOURNE, Australia and PRINCETON, N.J....